Maximus vs Oak Longevity: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Oak Longevity beats Maximus overall, scoring 7.5/10 vs 7.1/10. Oak Longevity is more affordable at $133/mo vs $150/mo. Choose Maximus for men who want glp-1 alongside testosterone or other men's hea. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.
A side-by-side look at Maximus and Oak Longevity to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Maximus
#45 of 53Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.
Visit MaximusOak Longevity
#25 of 53Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing, patients pay each month manually rather than auto-renew.
Visit Oak Longevity| Feature | Maximus | Oak Longevity |
|---|---|---|
| Our Score | 7.1/10 | 7.5/10 |
| Starting Price | $150/mo | $133/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Men who want GLP-1 alongside testosterone or other men's health protocols | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) |
| Watch out for | The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro | Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct |
| Ranking | #45 | #25 |
| Get started | Visit Maximus | Visit Oak Longevity |
Pros & Cons Compared
Maximus
Pros
- +Lowest entry price in the market, $79.99/mo microdose semaglutide, $99.99/mo 3-month starter pack
- +GLP-1 microdosing available for BMI as low as 22, the only platform serving patients below standard obesity criteria
- +Nausea-reducing formula with added glycine and B12 to ease GLP-1 side effects
- +Free expedited shipping on all medication orders
Cons
- −The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
- −Compounding pharmacy partners are not disclosed, a transparency gap for a healthcare platform
- −Bulk-plan prices rise as your dose escalates; ask for the full dose-price schedule up front so total cost isn't a surprise
Oak Longevity
Pros
- +$133/mo for compounded semaglutide is among the cheapest entries on the market, Sesame Care ($99) is lower, but Oak undercuts most mid-tier platforms
- +No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician, useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct
- −No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
- −The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
- −The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits
Our Verdict
Oak Longevity edges out Maximus with a score of 7.5/10 vs 7.1/10. If budget is your priority, Oak Longevity starts at $133/mo compared to Maximus's $150/mo. Oak Longevity offers both brand-name and compounded medications, giving you more flexibility. Choose Maximus if you want: men who want glp-1 alongside testosterone or other men's health protocols. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Maximus nor Oak Longevity feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Maximus or Oak Longevity tend to look at next.
- Maximus vs PeterMD$165/mo
- Maximus vs TrimRx$149/mo
- Maximus vs Strut Health$149/mo
- Oak Longevity vs Found$129/mo
- Oak Longevity vs GobyMeds$169/mo
- Oak Longevity vs bmiMD$119/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.